NCT01755507View on ClinicalTrials.gov

Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis

PHASE2CompletedINTERVENTIONAL
Enrollment

159

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

October 31, 2015

Study Completion Date

December 31, 2015

Conditions
Primary Sclerosing Cholangitis
Interventions
DRUG

norUDCA

Comparison of different dosages of norUDCA acid administered orally.

DRUG

Placebo

Trial Locations (3)

1090

Prof. M. Trauner, Vienna

30623

Prof. Michael Manns, Hanover

0424

Kirsten Boberg, Oslo

Sponsors
All Listed Sponsors
lead

Dr. Falk Pharma GmbH

INDUSTRY